Heidi Tikkanen-Dolenc1,2,3, Johan Wadén1,2,3, Carol Forsblom1,2,3, Valma Harjutsalo1,2,3,4, Lena M Thorn1,2,3, Markku Saraheimo1,2,3, Nina Elonen1,2,3, Milla Rosengård-Bärlund1,2,3, Daniel Gordin1,2,3, Heikki O Tikkanen5,6,7, Per-Henrik Groop8,9,10,11. 1. Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland. 2. Abdominal Center Nephrology, University of Helsinki and Helsinki University Central Hospital, Biomedicum Helsinki, Haartmaninkatu 8, FIN - 00290, Helsinki, Finland. 3. Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland. 4. Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland. 5. Department of Sports and Exercise Medicine, Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland. 6. Foundation for Sports and Exercise Medicine, Clinic for Sports and Exercise Medicine, Helsinki, Finland. 7. School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland. 8. Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland. per-henrik.groop@helsinki.fi. 9. Abdominal Center Nephrology, University of Helsinki and Helsinki University Central Hospital, Biomedicum Helsinki, Haartmaninkatu 8, FIN - 00290, Helsinki, Finland. per-henrik.groop@helsinki.fi. 10. Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland. per-henrik.groop@helsinki.fi. 11. Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. per-henrik.groop@helsinki.fi.
Abstract
AIMS/HYPOTHESIS: Cardiovascular disease (CVD) is the most common cause of premature death and disability among patients with type 1 diabetes. Diabetic nephropathy accounts for the increased cardiovascular morbidity and mortality of these patients. We recently showed that the intensity of exercise predicts the incidence and progression of diabetic nephropathy in patients with type 1 diabetes. Little is known about the relationship between physical activity and CVD. Therefore, we studied how physical activity affects the risk of CVD events in patients with type 1 diabetes. METHODS: A 10 year follow-up study including 2180 type 1 diabetes patients from the nationwide multicentre Finnish Diabetic Nephropathy Study (FinnDiane). Leisure time physical activity (LTPA) was assessed by a previously validated self-report questionnaire. A CVD event was defined as a verified myocardial infarction, coronary procedure or stroke. Patients were analysed separately for the risk of developing a first ever CVD event and for the risk of a recurrent CVD event following a baseline event. RESULTS: A total of 206 patients had an incident CVD event during follow-up. A higher total LTPA and higher intensity, frequency and duration of activity were associated with a lower risk of incident CVD events. The observed association between exercise frequency and incident CVD remained significant when adjusted for classic risk factors. Exercise intensity also had a borderline effect on the recurrence-free time in patients with a major CVD event at baseline. CONCLUSIONS/ INTERPRETATION: This study suggests that exercise, particularly high frequency and high intensity exercise, may reduce the risk of CVD events in patients with type 1 diabetes.
AIMS/HYPOTHESIS: Cardiovascular disease (CVD) is the most common cause of premature death and disability among patients with type 1 diabetes. Diabetic nephropathy accounts for the increased cardiovascular morbidity and mortality of these patients. We recently showed that the intensity of exercise predicts the incidence and progression of diabetic nephropathy in patients with type 1 diabetes. Little is known about the relationship between physical activity and CVD. Therefore, we studied how physical activity affects the risk of CVD events in patients with type 1 diabetes. METHODS: A 10 year follow-up study including 2180 type 1 diabetespatients from the nationwide multicentre Finnish Diabetic Nephropathy Study (FinnDiane). Leisure time physical activity (LTPA) was assessed by a previously validated self-report questionnaire. A CVD event was defined as a verified myocardial infarction, coronary procedure or stroke. Patients were analysed separately for the risk of developing a first ever CVD event and for the risk of a recurrent CVD event following a baseline event. RESULTS: A total of 206 patients had an incident CVD event during follow-up. A higher total LTPA and higher intensity, frequency and duration of activity were associated with a lower risk of incident CVD events. The observed association between exercise frequency and incident CVD remained significant when adjusted for classic risk factors. Exercise intensity also had a borderline effect on the recurrence-free time in patients with a major CVD event at baseline. CONCLUSIONS/ INTERPRETATION: This study suggests that exercise, particularly high frequency and high intensity exercise, may reduce the risk of CVD events in patients with type 1 diabetes.
Entities:
Keywords:
Cardiovascular disease; Exercise; Leisure-time physical activity; Type 1 diabetes
Authors: Johan Wadén; Carol Forsblom; Lena M Thorn; Markku Saraheimo; Milla Rosengård-Bärlund; Outi Heikkilä; Timo A Lakka; Heikki Tikkanen; Per-Henrik Groop Journal: Diabetes Care Date: 2007-10-24 Impact factor: 19.112
Authors: Johan Wadén; Heidi K Tikkanen; Carol Forsblom; Valma Harjutsalo; Lena M Thorn; Markku Saraheimo; Nina Tolonen; Milla Rosengård-Bärlund; Daniel Gordin; Heikki O Tikkanen; Per-Henrik Groop Journal: Diabetologia Date: 2015-01-30 Impact factor: 10.122
Authors: F B Hu; R J Sigal; J W Rich-Edwards; G A Colditz; C G Solomon; W C Willett; F E Speizer; J E Manson Journal: JAMA Date: 1999-10-20 Impact factor: 56.272
Authors: Mihaela Tanasescu; Michael F Leitzmann; Eric B Rimm; Walter C Willett; Meir J Stampfer; Frank B Hu Journal: JAMA Date: 2002 Oct 23-30 Impact factor: 56.272
Authors: Arnt Erik Tjønna; Sang Jun Lee; Øivind Rognmo; Tomas O Stølen; Anja Bye; Per Magnus Haram; Jan Pål Loennechen; Qusai Y Al-Share; Eirik Skogvoll; Stig A Slørdahl; Ole J Kemi; Sonia M Najjar; Ulrik Wisløff Journal: Circulation Date: 2008-07-07 Impact factor: 29.690
Authors: Ravi Reddy; Navid Resalat; Leah M Wilson; Jessica R Castle; Joseph El Youssef; Peter G Jacobs Journal: J Diabetes Sci Technol Date: 2019-01-17
Authors: C Blanc-Bisson; F L Velayoudom-Cephise; A Cougnard-Gregoire; C Helmer; K Rajaobelina; C Delcourt; L Alexandre; L Blanco; K Mohammedi; M Monlun; V Rigalleau Journal: Cardiovasc Diabetol Date: 2018-06-08 Impact factor: 9.951
Authors: Heidi Tikkanen-Dolenc; Johan Wadén; Carol Forsblom; Valma Harjutsalo; Lena M Thorn; Markku Saraheimo; Nina Elonen; Kustaa Hietala; Paula Summanen; Heikki O Tikkanen; Per-Henrik Groop Journal: Acta Diabetol Date: 2019-11-20 Impact factor: 4.280